The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120
泰国 III 期 HIV 1 型疫苗试验 (RV144) 方案诱导针对 gp120 V2 环内保守区域的抗体
期刊:Aids Research and Human Retroviruses
影响因子:1.5
doi:10.1089/aid.2012.0103
Nicos Karasavvas, Erik Billings, Mangala Rao, Constance Williams, Susan Zolla-Pazner, Robert T Bailer, Richard A Koup, Sirinan Madnote, Duangnapa Arworn, Xiaoying Shen, Georgia D Tomaras, Jeffrey R Currier, Mike Jiang, Craig Magaret, Charla Andrews, Raphael Gottardo, Peter Gilbert, Timothy J Cardozo
